微信公众号
证券之星APP
| 报告期 | 销售毛利率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 60.71% | -24.47% | -14.58% | 50/131 | 51.25% | 佰仁医疗 | 85.72% | 行业排名> |
| 2024-12-31 | 71.07% | -14.03% | -4.55% | 22/131 | 52.33% | 佰仁医疗 | 88.34% | 行业排名> |
| 2024-09-30 | 74.46% | -10.43% | -2.97% | 17/131 | 53.43% | 佰仁医疗 | 88.56% | 行业排名> |
| 2024-06-30 | 76.74% | -6.9% | -4.53% | 13/131 | 53.5% | 佰仁医疗 | 89.27% | 行业排名> |
| 2024-03-31 | 80.38% | -0.76% | -2.78% | 9/131 | 53.43% | 佰仁医疗 | 89.28% | 行业排名> |
| 2023-12-31 | 82.67% | -0.84% | -0.55% | 4/131 | 53.31% | 正海生物 | 89.9% | 行业排名> |
| 2023-09-30 | 83.13% | -0.05% | 0.86% | 4/131 | 54.06% | 正海生物 | 90.39% | 行业排名> |
| 2023-06-30 | 82.42% | -0.32% | 1.76% | 6/131 | 53.45% | 正海生物 | 90.3% | 行业排名> |
| 2023-03-31 | 80.99% | -1.5% | -2.86% | 7/131 | 53.66% | 正海生物 | 89.78% | 行业排名> |
| 2022-12-31 | 83.38% | -2.32% | 0.25% | 6/131 | 53.83% | 三友医疗 | 90.18% | 行业排名> |
| 2022-09-30 | 83.17% | -3.21% | 0.58% | 8/131 | 55.13% | 三友医疗 | 90.14% | 行业排名> |
| 2022-06-30 | 82.69% | -3.87% | 0.56% | 8/131 | 54.78% | 三友医疗 | 90.29% | 行业排名> |
| 2022-03-31 | 82.23% | -4.09% | -3.66% | 8/131 | 56.28% | 三友医疗 | 90.73% | 行业排名> |
| 2021-12-31 | 85.35% | 1.85% | -0.67% | 4/131 | 57.29% | 三友医疗 | 90.5% | 行业排名> |
| 2021-09-30 | 85.93% | 2% | -0.09% | 4/131 | 59.17% | 三友医疗 | 90.29% | 行业排名> |
| 2021-06-30 | 86.01% | 6.68% | 0.33% | 4/131 | 58.42% | 正海生物 | 90.78% | 行业排名> |
| 2021-03-31 | 85.73% | 2% | 2.3% | 5/131 | 60.75% | 正海生物 | 91.59% | 行业排名> |
| 2020-12-31 | 83.81% | 1.11% | 3.94% | 9/131 | 59.59% | 正海生物 | 92.23% | 行业排名> |
| 2020-06-30 | 80.63% | 2% | -2.72% | 16/131 | 59.94% | 正海生物 | 92.69% | 行业排名> |
| 2019-12-31 | 82.88% | -0.35% | -0.35% | 13/131 | 56.37% | 正海生物 | 92.61% | 行业排名> |
| 2018-12-31 | 83.18% | 4.42% | 4.42% | 8/131 | 55.53% | 正海生物 | 94.38% | 行业排名> |
| 2017-12-31 | 79.66% | 2% | 2% | 14/131 | 55.34% | 正海生物 | 93.12% | 行业排名> |